Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

Covering State Level Legislation and Regulations Impacting Patient Services, Access, and Affordability

In this Pharmaceutical Executive video interview, Jon Hamrick, Partner, Curatio Scientia Advisors and Jon Rawlson, President & Founder, Armory Hill Advocates, discuss what’s stopping companies from investing in covering state level legislation and regulations impacting patient services, access, and affordability.

Migraine Treatment Comes in Different Forms, Allowing for Patient Preference

With migraine as a leading disability for those under the age of 50, treatment options for migraine should be personalized to the patient and their needs.

Microsoft Makes a New Push Into Smaller A.I. Systems

The company that has invested billions in generative A.I. pioneers like OpenAI says giant systems aren’t necessarily what everyone needs.

AndHealth Partners with PrimaryOne Health to Address Health Inequities by Offering In-House Specialty Care

AndHealth announced its partnership with PrimaryOne Health to bring in-house whole-person specialty care to the communities they serve. PrimaryOne Health supports Franklin County and Pickaway County as the oldest and largest Community Health Center in central Ohio. Through this partnership, PrimaryOne Health will now add high-quality and affordable in-house specialty care for dermatology (including psoriasis, psoriatic arthritis), rheumatology (including rheumatoid arthritis), and neurology (including headache and migraine) to its services.

@EVERSANAcompany on Twitter/X:

Navigating healthcare journeys is complex. Maria Kirsch shares hers insights with @PharmaCommerce on how manufacturers can harness the power of technology to overcome barriers and empower patients along the way: https://pharmaceuticalcommerce.com/view/the-power-of-patient-adherence-tools-to-improve-the-patient-journey

#HealthcareInnovation

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs